Focused Wealth Management’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-110
| Closed | -$153 | – | 1022 |
|
|
2023
Q4 | $153 | Hold |
110
| – | – | ﹤0.01% | 962 |
|
|
2023
Q3 | $154 | Hold |
110
| – | – | ﹤0.01% | 971 |
|
|
2023
Q2 | $202 | Hold |
110
| – | – | ﹤0.01% | 998 |
|
|
2023
Q1 | $267 | Hold |
110
| – | – | ﹤0.01% | 972 |
|
|
2022
Q4 | $157 | Hold |
110
| – | – | ﹤0.01% | 1028 |
|
|
2022
Q3 | $0 | Hold |
110
| – | – | ﹤0.01% | 1078 |
|
|
2022
Q2 | $0 | Hold |
110
| – | – | ﹤0.01% | 1106 |
|
|
2022
Q1 | $0 | Hold |
110
| – | – | ﹤0.01% | 1135 |
|
|
2021
Q4 | $0 | Hold |
110
| – | – | ﹤0.01% | 1120 |
|
|
2021
Q3 | $0 | Hold |
110
| – | – | ﹤0.01% | 1125 |
|
|
2021
Q2 | $0 | Hold |
110
| – | – | ﹤0.01% | 1050 |
|
|
2021
Q1 | $0 | Hold |
110
| – | – | ﹤0.01% | 1026 |
|
|
2020
Q4 | $0 | Hold |
110
| – | – | ﹤0.01% | 921 |
|
|
2020
Q3 | $0 | Hold |
110
| – | – | ﹤0.01% | 885 |
|
|
2020
Q2 | $0 | Hold |
110
| – | – | ﹤0.01% | 845 |
|
|
2020
Q1 | $0 | Hold |
110
| – | – | ﹤0.01% | 789 |
|
|
2019
Q4 | $0 | Hold |
110
| – | – | ﹤0.01% | 784 |
|
|
2019
Q3 | $0 | Hold |
110
| – | – | ﹤0.01% | 790 |
|
|
2019
Q2 | $0 | Hold |
110
| – | – | ﹤0.01% | 818 |
|
|
2019
Q1 | $0 | Hold |
110
| – | – | ﹤0.01% | 765 |
|
|
2018
Q4 | $0 | Hold |
110
| – | – | ﹤0.01% | 766 |
|
|
2018
Q3 | $0 | Hold |
110
| – | – | ﹤0.01% | 728 |
|
|
2018
Q2 | $1K | Hold |
110
| – | – | ﹤0.01% | 622 |
|
|
2018
Q1 | $1K | Hold |
110
| – | – | ﹤0.01% | 674 |
|
|
2017
Q4 | $1K | Hold |
110
| – | – | ﹤0.01% | 659 |
|
|
2017
Q3 | $1K | Hold |
110
| – | – | ﹤0.01% | 626 |
|
|
2017
Q2 | $1K | Hold |
110
| – | – | ﹤0.01% | 681 |
|
|
2017
Q1 | $1K | Hold |
110
| – | – | ﹤0.01% | 666 |
|
|
2016
Q4 | $1K | Hold |
110
| – | – | ﹤0.01% | 667 |
|
|
2016
Q3 | $1K | Hold |
110
| – | – | ﹤0.01% | 646 |
|
|
2016
Q2 | $1K | Hold |
110
| – | – | ﹤0.01% | 645 |
|
|
2016
Q1 | $1K | Hold |
110
| – | – | ﹤0.01% | 625 |
|
|
2015
Q4 | $0 | Hold |
110
| – | – | ﹤0.01% | 734 |
|
|
2015
Q3 | $0 | Hold |
110
| – | – | ﹤0.01% | 727 |
|
|
2015
Q2 | $0 | Hold |
110
| – | – | ﹤0.01% | 710 |
|
|
2015
Q1 | $0 | Hold |
110
| – | – | ﹤0.01% | 709 |
|
|
2014
Q4 | $0 | Hold |
110
| – | – | ﹤0.01% | 718 |
|
|
2014
Q3 | $1K | Hold |
110
| – | – | ﹤0.01% | 658 |
|
|
2014
Q2 | $1K | Buy |
+110
| New | +$476 | ﹤0.01% | 641 |
|
Other funds holding ENZ
HFA
TCM
RC
BCM
Focused Wealth Management's ENZ Position: Q1 2024 in Review
Focused Wealth Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2024, closing a stake of 110 shares — an estimated $153 sold.
Focused Wealth Management first reported a position in ENZ in Q2 2014 and held it in 39 quarters. The position peaked at $1K in Q2 2018. 41 funds tracked by Wall St. Rank hold ENZ as of Q1 2024.
- Focused Wealth Management reported no remaining Enzo Biochem, Inc. position as of Q1 2024 after selling out during the quarter.
- Focused Wealth Management sold 110 Enzo Biochem, Inc. shares in Q1 2024, an estimated $153.
- Focused Wealth Management first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 39 quarters.
- Focused Wealth Management's Enzo Biochem, Inc. position peaked at $1K in Q2 2018.
- 41 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2024.
Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.